Kaj je DESCRIBED IN SECTIONS v Slovenščini - Slovenski prevod

• opisani v poglavjih
• opisani v oddelkih

Primeri uporabe Described in sections v Angleški in njihovi prevodi v Slovenski

Available data are described in sections 4.8, 5.1 and 5.2.
Trenutni razpoložljivi podatki so opisani v poglavjih 4.8, 5.1 in 5.2.

Licensee and Third Party use of such modifications and derivatives is limited to the license rights described in Sections this Agreement.
Uporaba takšnih sprememb in izpeljank s strani pridobitelja licence in tretjih strank je omejena na licenčne pravice, opisane v razdelkih te pogodbe.

Available data are described in sections 5.1 and 5.2 but no recommendation on a posology can be made.
Razpoložljivi podatki so opisani v poglavjih 5.1 in 5.2, vendar priporočil o odmerjanju ni mogoče dati.

In order to allow technological innovation, these specifications and assessment methods shall be developed by the process described in sections 6.2.3.
Da se omogočijo tehnološke inovacije, se te specifikacije in metode ocenjevanja razvijejo po postopku, opisanem v oddelku 6.2.3.

Currently available data are described in sections 4.4 and 5.1 but no recommendation on a posology can be made.
Na podlagi zadnjih dostopnih podatkov, ki so opisani v poglavjih 4.4 in 5.1 ni mogoče priporočati uporabe.

In order to allow technological innovation, these specifications and assessment methods shall be developed by the process described in sections 6.1.4 and 6.2.4.
Da bi se omogočile tehnološke inovacije, se te specifikacije in metode ocenjevanja razvijajo po postopku, opisanem v oddelkih 6.1.4 in 6.2.4.

Currently available data are described in sections 4.8 and 5.1 but no recommendation on a posology can be made.
Trenutno razpoložljivi podatki so opisani v poglavju 4.8 in 5.1, vendar priporočil o odmerjanju ni mogoče dati.

In the case of an immunological veterinary medicinal products containing a live organism, the dose to be used in the laboratory tests described in Sections B. 1 and B.
Kadar imunološko zdravilo za uporabo v veterinarski medicini vsebuje živ organizem, je odmerek, ki se uporabi v laboratorijskih preskusih, opisanih v oddelkih B.1 in B.

Currently available data are described in sections 4.4 and 5.1 but no recommendation on a posology can be made.
Na podlagi zadnjih dostopnih podatkov, ki so opisani v poglavjih 4.4 in 5.1 ni mogoče dati priporočil glede odmerjanja.

When a device is put into service, Member States may require the information described in sections 13, 14 and 15 of Annex 1 to be in their national language(s).
Ko se pripomoček začne uporabljati, lahko države članice zahtevajo, da so podatki, opisani v oddelkih 13, 14 in 15 Priloge 1, napisani v njihovem nacionalnem(ih) jeziku(ih).

Current available data are described in sections 4.4, 4.8, 5.1 and 5.2 but no recommendation on a posology can be made.
Podatki, ki so trenutno na voljo, so opisani v poglavjih 4.4, 4.8 in 5.1, a priporočil za odmerjanje ni mogoče dati.

Exporting producers, Union producers, importers and representative associations who made information available in accordance to the procedures described in sections 5.3, 5.4 and 5.5 above will be considered as interested parties if there is an objective link between their activities and the product under investigation.
Proizvajalce izvoznike, proizvajalce Unije, uvoznike in reprezentativna združenja, ki so dali na voljo informacije v skladu s postopki, ki so opisani v oddelkih 5.3, 5.4 in 5.5 zgoraj, je treba obravnavati kot zainteresirane strani, če obstaja dejanska povezava med njihovimi dejavnostmi in izdelkom v preiskavi.

Currently available data are described in sections 4.8, 5.1, 5.2 and 5.3 but no recommendation on a posology can be made.
Podatki, ki so trenutno na voljo, so opisani v poglavjih 4.8, 5.1, 5.2 in 5.3, vendar priporočil o odmerjanju ni mogoče dati.

Currently available data in adolescents from 12 to 17 years are described in sections 4.8, 5.1 and 5.2, but no recommendation on a posology can be made.
Trenutno razpoložljivi podatki za mladostnike, stare od 12 do 17 let, so opisani v poglavjih 4.8, 5.1 in 5.2, vendar priporočil o odmerjanju ni mogoče dati.

Currently available data are described in sections 4.8 and 5.1. AZOPT is not recommended for use in infants, children and adolescents.
Trenutno razpoložljivi podatki so opisani v poglavju 4.8 in 5.1. Uporaba zdravila AZOPT pri dojenčkih, otrocih in mladostnikih ni priporočljiva.

Finally, it is important to note that even where a particular material satisfies the tests set out by the ECJ(and described in sections 3.3) in order to be considered as a non-waste, if it is in practice discarded, it must clearly be considered and treated as a waste.
Nazadnje je pomembno opomniti, da tudi kjer material izpolnjuje preskuse, ki jih določa Sodišče Evropskih skupnosti(in so opisani v poglavjih 3.3), se ga mora jasno obravnavati in obdelovati kot odpadek, da se ga lahko šteje za ne-odpadek, če je v praksi zavržen.

With the exception of the processing described in Sections 3.2 and 5, we will not forward your personal data to recipients established outside the European Union or the European Economic Area.
Razen vrst obdelave, predstavljenih v poglavjih 3.2 in 5, vaših osebnih podatkov ne posredujemo prejemnikom s sedežem zunaj Evropske unije ali Evropskega gospodarskega prostora.

Currently available limited data are described in sections 4.8, 5.1, and 5.2 but no recommendation on a posology can be made.
Trenutno razpoložljivi omejeni podatki so opisani v poglavjih 4.8, 5.1 in 5.2, vendar priporočil o odmerjanju ni mogoče dati.

Currently available data are described in sections 4.8, 5.1 and 5.2, but no recommendation on a posology can be made.
Trenutno razpoložljivi podatki so opisani v poglavjih 4.8, 5.1 in 5.2, vendar ni mogoče dati priporočila za odmerjanje.

Currently available data are described in sections 5.1 and 5.2 but no recommendation on a posology can be made.
Podatki, ki so trenutno na razpolago, so opisani v poglavjih 5.1 in 5.2, toda priporočil glede odmerjanja ni mogoče postaviti.

Currently available data are described in sections 4.8, 5.1, and 5.2 but no recommendation on a posology can be made.
Trenutno dostopni podatki so opisani v poglavjih 4.8, 5.1 in 5.2, vendar priporočil za določanje odmerjanja ni mogoče izdelati.

These effects are described in section 4,‘Possible side effects'.
Takšni neželeni učinki so opisani v poglavju 4,“Možni neželeni učinki”.

Signs and symptoms of kidney disease are described in section 4.
Znaki in simptomi bolezni ledvic so opisani v poglavju 4.

Currently available data on paediatric use are described in section 5.1.
Trenutno razpoložljivi podatki o pediatrični uporabi so opisani v poglavju 5.1.

Reconstitute the lyophilisate as described in section 6.6. Initial intravenous bolus:.
Rekonstituirajte liofilizat, kot je opisano v poglavju 6.6. Začetni intravenski bolus:.

Details are described in Section 6.2.7.
Podrobnosti so navedene v oddelku 6.2.

Available pharmacokinetic data are described in section 5.2.
Farmakokinetične informacije so navedene v poglavju 5.2.

The procedure for reconstitution is described in section 6.6.
Postopek rekonstitucije je opisan v poglavju 6. 6.